Can systemic sclerosis (scleroderma) cause severe pain in the hands and feet?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, systemic sclerosis commonly causes severe pain in hands and feet

Systemic sclerosis (SSc) is a well-established cause of severe pain in the hands and feet, with over 90% of patients experiencing various types of pain, and nearly half suffering from daily pain. 1

Pain Patterns in Hands and Feet

The hands and feet are among the most frequently affected sites in SSc, with multiple pain mechanisms:

Hand Pain

  • Joint pain is the most common type, occurring in 78.6% of SSc patients 1
  • Raynaud's phenomenon-related pain affects 69% of patients, triggered by cold exposure and temperature changes 1
  • Digital ulcer pain occurs in 19% of patients and is associated with significant depression 1
  • Neuropathic pain symptoms are present in 26.2% of patients 1

Foot Pain

Recent evidence demonstrates that foot involvement is equally problematic:

  • Forefoot pain occurs in 50.5% of patients 2
  • Hindfoot pain affects 31.7% of patients 2
  • 82% of patients report foot pain, usually related to cold exposure 3
  • Foot ulceration occurs in 26% of patients over their disease course 3

Clinical Significance and Impact

The severity of pain in SSc directly correlates with disease severity, depression, and quality of life. 1 Specifically:

  • Severe joint pain, everyday pain, and neuropathic pain are associated with more severe disease and poorer quality of life 1
  • Pain related to Raynaud's phenomenon, digital ulcers, and joint pain correlate with significant depressive symptoms 1
  • Higher foot pain scores and dysfunction are linked to disability measures (HAQ-DI and SHAQ) 2

Pathophysiologic Mechanisms

The pain arises from multiple SSc-related processes:

  1. Vascular manifestations: Raynaud's phenomenon causes ischemic pain through vasospasm and delayed reperfusion 4
  2. Tissue fibrosis: Skin and soft tissue involvement restricts movement and causes mechanical pain
  3. Inflammatory arthritis: Joint inflammation occurs in 61% of patients with radiological erosions in 40% 5
  4. Digital ulceration: Ischemic ulcers cause severe localized pain
  5. Neuropathic changes: Nerve involvement contributes to burning, tingling pain

Clinical Pitfalls

A critical gap exists in clinical practice: 36.6% of SSc patients report never having their feet examined, and only 32.7% had foot examinations within the past year 2. This represents a significant oversight given the high prevalence of foot problems.

Additional foot abnormalities often missed include:

  • Pre-ulcerative lesions (34%) 3
  • Toenail changes (62%) 3
  • Callus formation (80%) 3
  • Calcinosis (18%) 3

Management Considerations

While the 2025 EULAR guidelines 6 prioritize treatment recommendations for major organ manifestations (skin fibrosis, ILD, PAH), they specifically identify musculoskeletal manifestations as a priority for future research 6. Current non-pharmacological recommendations include:

  • Cold avoidance and protective measures (gloves, heating devices) for Raynaud's phenomenon-related pain 4
  • Physical exercise and hand therapy should be considered for improving hand function 4
  • Regular foot examinations and appropriate footwear (40% of patients have shoe-fitting problems) 3

The pain in SSc hands and feet is multifactorial, severe, and undertreated, requiring systematic assessment and management as part of comprehensive SSc care.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.